Main Menu

ICR Clinical Trials and Statistics Unit

The ICR Clinical Trials and Statistics Unit (ICR-CTSU) leads the design, conduct and analysis of phase II and III national and international cancer clinical trials. Our findings directly influence clinical practice within the NHS and worldwide.

clinical trial

Our clinical trials

ICR-CTSU clinical trials focus on breast, urological and head and neck cancers, but we also run trials in other rarer cancer types including melanoma, sarcoma and ovarian cancer. We specialise in phase II exploratory and phase III randomised trials of new treatments and technologies (including radiotherapy), and understanding cancer biology and treatment response using biomarker-driven trial designs is fundamental to our research.

More information about the different clinical trials we run can be found on the clinical trials pages.

For patients and the public

To find out more about ICR-CTSU research, including how to become involved in clinical trials, please visit our patients and public page. In addition, most clinical trial pages include a link to the study’s plain English summary.

For researchers

ICR-CTSU is a research-led, academic clinical trials unit (CTU) within the Division of Clinical Studies at the ICR. Our expertise spans the whole clinical trial life cycle. We receive core funding from Cancer Research UK, are a UK Clinical Research Collaborative (UKCRC) registered CTU and one of 15 CTUs recognised by the National Cancer Research Institute (NCRI) for professional specialism in the development and delivery of cancer trials.

If you are interested in working with us, please visit our collaborators’ page or explore current ICR vacancies.

Current vacancies

Division of Clinical Studies

The division carries out or coordinates high-quality trials and translational research at both an early phase – typically to test new targeted drugs – and a later stage.

We use cookies to ensure that we give you the best experience on our website. By continuing to use this website, you are agreeing to our use of cookies on your device as described in our cookie policy. You can change your cookie settings at any time but parts of our site will not function correctly without them.